HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Bile Duct Cancer

Bile Duct Cancer

Bile duct cancer, medically termed cholangiocarcinoma, presents a formidable challenge in the realm of oncology. Though relatively uncommon, its aggressive nature demands intensive research efforts. Recent strides in cancer exploration have unveiled the intricate molecular pathways underpinning this malignancy. This newfound understanding has paved the way for targeted therapies tailored to specific genetic aberrations. Moreover, innovative immunotherapeutic interventions hold promise in bolstering the body's immune response against cancerous cells. Concurrently, endeavors to refine early detection techniques and customize treatment regimens are underway, offering a glimpse of optimism for patients grappling with this formidable adversary. The ongoing pursuit of knowledge and innovation in bile duct cancer research is pivotal, holding the potential to transform prognoses and enhance the lives of those affected by this insidious disease.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp